CAI
ABBV icon

Capital Advisors Inc’s AbbVie ABBV Stock Holding History

Capital Advisors Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113M Buy
447,129
+45,132
+11% +$9.71M 1.66% 12
2026
Q1 		$87.4M Buy
401,997
+11,427
+3% +$2.53M 1.41% 18
2025
Q4 		$89.2M Buy
390,570
+8,922
+2% +$2.03M 1.44% 15
2025
Q3 		$88.4M Buy
381,648
+34,548
+10% +$7.04M 1.48% 14
2025
Q2 		$64.4M Buy
347,100
+296
+0.1% +$55K 1.16% 23
2025
Q1 		$72.7M Buy
346,804
+11,793
+4% +$2.29M 1.45% 18
2024
Q4 		$59.5M Buy
335,011
+5,119
+2% +$941K 1.19% 22
2024
Q3 		$65.1M Sell
329,892
-22,701
-6% -$4.24M 1.3% 17
2024
Q2 		$60.5M Buy
352,593
+8,279
+2% +$1.37M 1.25% 18
2024
Q1 		$62.7M Sell
344,314
-64,229
-16% -$11.1M 1.35% 17
2023
Q4 		$63.3M Buy
408,543
+30,898
+8% +$4.5M 1.42% 16
2023
Q3 		$56.3M Buy
377,645
+7,924
+2% +$1.16M 1.47% 16
2023
Q2 		$49.8M Buy
369,721
+21,876
+6% +$3.21M 1.27% 23
2023
Q1 		$55.4M Buy
347,845
+4,436
+1% +$678K 1.49% 17
2022
Q4 		$55.5M Buy
343,409
+824
+0.2% +$126K 1.57% 13
2022
Q3 		$49M Buy
342,585
+9,130
+3% +$1.31M 1.52% 16
2022
Q2 		$51.1M Buy
333,455
+5,692
+2% +$870K 1.53% 17
2022
Q1 		$53.1M Buy
327,763
+4,409
+1% +$640K 1.46% 17
2021
Q4 		$43.8M Buy
323,354
+453
+0.1% +$53.5K 1.17% 25
2021
Q3 		$34.8M Buy
322,901
+1,086
+0.3% +$124K 1.04% 28
2021
Q2 		$36.2M Buy
321,815
+7,483
+2% +$843K 1.09% 26
2021
Q1 		$34M Buy
314,332
+9,925
+3% +$1.06M 1.11% 25
2020
Q4 		$32.6M Buy
304,407
+9,105
+3% +$875K 1.16% 20
2020
Q3 		$25.9M Buy
295,302
+4,442
+2% +$418K 1.05% 30
2020
Q2 		$26.9M Buy
290,860
+5,411
+2% +$476K 1.12% 25
2020
Q1 		$21.7M Buy
285,449
+257,210
+911% +$21.9M 1.18% 19
2019
Q4 		$2.5M Buy
28,239
+369
+1% +$30.6K 0.11% 97
2019
Q3 		$2.03M Hold
27,870
– – 0.1% 103
2019
Q2 		$2.03M Buy
+27,870
New +$2.19M 0.1% 103
2019
Q1 		– Sell
-29,139
Closed -$2.69M – 130
2018
Q4 		$2.69M Buy
29,139
+1,279
+5% +$112K 0.17% 92
2018
Q3 		$2.63M Buy
27,860
+125
+0.5% +$11.9K 0.16% 97
2018
Q2 		$2.57M Sell
27,735
-75
-0.3% -$7.33K 0.15% 101
2018
Q1 		$2.63M Sell
27,810
-1,485
-5% -$163K 0.16% 102
2017
Q4 		$2.83M Buy
29,295
+1,392
+5% +$131K 0.17% 98
2017
Q3 		$2.48M Sell
27,903
-2,570
-8% -$196K 0.15% 97
2017
Q2 		$2.21M Buy
30,473
+101
+0.3% +$6.79K 0.14% 98
2017
Q1 		$1.98M Sell
30,372
-181
-0.6% -$11.4K 0.13% 93
2016
Q4 		$1.91M Buy
30,553
+17,798
+140% +$1.09M 0.13% 92
2016
Q3 		$804K Sell
12,755
-393
-3% -$25.4K 0.12% 77
2016
Q2 		$814K Hold
13,148
– – 0.13% 79
2016
Q1 		$751K Buy
13,148
+1
+0% +$56 0.12% 80
2015
Q4 		$779K Buy
13,147
+269
+2% +$15.5K 0.14% 78
2015
Q3 		$701K Buy
12,878
+32
+0.2% +$2.08K 0.13% 81
2015
Q2 		$863K Buy
12,846
+1,000
+8% +$65.3K 0.15% 69
2015
Q1 		$693K Hold
11,846
– – 0.09% 82
2014
Q4 		$775K Buy
11,846
+346
+3% +$21.8K 0.14% 75
2014
Q3 		$664K Hold
11,500
– – 0.14% 70
2014
Q2 		$649K Hold
11,500
– – 0.13% 73
2014
Q1 		$591K Hold
11,500
– – 0.13% 68
2013
Q4 		$607K Hold
11,500
– – 0.13% 71
2013
Q3 		$514K Hold
11,500
– – 0.12% 75
2013
Q2 		$475K Buy
+11,500
New +$503K 0.13% 74

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Capital Advisors Inc's ABBV Position: Q2 2026 in Review

Capital Advisors Inc increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $9.71M and bringing the position to 447,129 shares worth $113M. The position accounts for 1.66% of the portfolio, ranked #12.

Capital Advisors Inc first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 1,938 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Capital Advisors Inc held 447,129 shares of AbbVie worth $113M as of Q2 2026.
  • Capital Advisors Inc bought 45,132 AbbVie shares in Q2 2026, an estimated $9.71M.
  • AbbVie made up 1.66% of Capital Advisors Inc's portfolio in Q2 2026, its #12 holding.
  • Capital Advisors Inc first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 1,938 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.